-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation
-
Emerging therapies in the management of hypertensive patients with osteoarthritis
Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Gianpaolo Reboldi , Paolo Verdecchia
Review Article: Clinical Investigation